Outcomes of Sipuleucel-T Therapy: Disposition of Comments

Outcomes of Sipuleucel-T Therapy
Disposition of Comments
Project ID: CANP0610

-------------------

The Agency for Healthcare Research and Quality's (AHRQ) Technology Assessment (TA) Program supports and is committed to the transparency of its review process. Therefore, invited peer review comments and public review comments are publicly posted on the TA Program Web site at http://www.ahrq.gov/clinic/techix.htm within 3 months after the associated final report is posted on this Web site.

This document presents the peer review comments and public review comments sent in response to the draft report, Outcomes of Sipuleucel-T Therapy: Technology Assessment Report, posted on the AHRQ Web site from November 17 to December 6, 2010. The final version of the report is available online: Outcomes of Sipuleucel-T Therapy.

Select for printable version (PDF file, 210 KB). PDF Help.
http://www.ahrq.gov/clinic/ta/comments/sipuleucel/sipuleucel-t_dispcomm.pdf
--------------------
full-text (large):
Outcomes of Sipuleucel-T Therapy: Disposition of Comments
Current as of April 2011

--------------------
Internet Citation:

Outcomes of Sipuleucel-T Therapy: Disposition of Comments. April 2011. Rockville, MD: Agency for Healthcare Research and Quality. http://www.ahrq.gov/clinic/ta/comments/sipuleucel/

--------------------